These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10022688)
21. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter. Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629 [TBL] [Abstract][Full Text] [Related]
22. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. Pirinen R; Hirvikoski P; Böhm J; Kellokoski J; Moisio K; Virén M; Johansson R; Hollmén S; Kosma VM Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576 [TBL] [Abstract][Full Text] [Related]
23. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome. Byun SS; Yeo WG; Lee SE; Lee E Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609 [TBL] [Abstract][Full Text] [Related]
24. Expression of CD44 standard and variant-v6 proteins in transitional cell bladder tumours and their relation to prognosis during a long-term follow-up. Lipponen P; Aaltoma S; Kosma VM; Ala-Opas M; Eskelinen M J Pathol; 1998 Oct; 186(2):157-64. PubMed ID: 9924431 [TBL] [Abstract][Full Text] [Related]
25. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract. Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025 [TBL] [Abstract][Full Text] [Related]
26. [Prognostic implication of morphometric stromal parameters of renal pelvis and ureteral transitional cell carcinomas]. Al'-Shukri CKh; Rybakova MG; Makovskaia AI; Tiurin AG; Kozlov VV; Ageev MN; Korneev IA Urologiia; 2004; (3):10-4. PubMed ID: 15199806 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis. Altinel M; Arpali E; Turhan N; Gonenc F; Yazicioglu A Urol Int; 2008; 81(4):452-5. PubMed ID: 19077409 [TBL] [Abstract][Full Text] [Related]
28. Are CD44 variant isoforms involved in human tumour progression? Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660 [TBL] [Abstract][Full Text] [Related]
29. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB. Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636 [TBL] [Abstract][Full Text] [Related]
30. CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker. Hoshimoto K; Yamauchi N; Takazawa Y; Onda T; Taketani Y; Fukayama M Pathol Res Pract; 2003; 199(2):71-7. PubMed ID: 12747468 [TBL] [Abstract][Full Text] [Related]
31. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic significance of expression of CD44s and CD44v6 isoforms in squamous cell carcinoma of the supraglottic larynx. Rodrigo JP; Domínguez F; Alvarez C; González MV; Herrero A; Suárez C Am J Clin Pathol; 2002 Jul; 118(1):67-72. PubMed ID: 12109858 [TBL] [Abstract][Full Text] [Related]
33. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
34. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms. Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350 [TBL] [Abstract][Full Text] [Related]
37. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma. Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541 [TBL] [Abstract][Full Text] [Related]
38. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073 [TBL] [Abstract][Full Text] [Related]
39. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas. Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000 [TBL] [Abstract][Full Text] [Related]
40. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival. Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]